AbFero Pharmaceuticals

AbFero Pharmaceuticals, Inc. is a privately held clinical-stage pharmaceutical company dedicated to developing treatments for iron overload disorders. Our therapeutic platform addresses transfusional iron overload (TIO) and iron accumulation associated with aging diseases, such as age-related macular degeneration (AMD) and Parkinson's disease.